Session date: 
01/23/2019 - 12:10pm to 1:00pm

Vera Bittner,  M.D.
Professor fo Medicine, University of Alabama at Birmingham
Section Head, General Cardiology, Prevention and Imaging
Medical Director, Coronary Care Unit
Medical Director, Cardiopulmonary Rehabilitation Program

 

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

  • Identify the current recommendations for ASCVD risk asessment in patients
  • Demonstrate the heterogeneity of risk among individuals with established ASCDVD and its impact on treatment recommendations
  • Cite current recommendations for lipid-lowering therapy in primary prevention setting

Financial Disclosures:

  • Consultant - Sanofi
  • Grant/Research Support - Amgen, Sanofi, Astra Zeneca, Esperion, DelCor, DalGene

Off Label/Investigational Uses:

  • None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Presenter: 
Vera Bittner, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota